Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxygen in acute pulmonary embolism
2024-511959-18-01Phase 3Authorised
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of oxygen in pulmonary embolism (PE) (2 arms), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Primary endpoint: Composite of hemodynamic collapse or death from any cause within 30 days after enrollment. Planned start Jul 2024; status: authorised.
02
Drugs
oxygen
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on 2024-511959-18-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511959-18-01.